For the Inventor, By the Inventor

Enter assignee name

Hayward, CA, United States of America

Lynx Therapeutics, Inc.

USPTO Granted Patents = 56

CIPO Patents = 1

Forward Citations = 10,147

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Sydney Brenner (28 out of 92 patents)

Sergei M Gryaznov (19 out of 83 patents)

Ronald G Schultz (10 out of 16 patents)

4. Stephen C Macevicz (8 out of 22 patents)

5. Glenn Albrecht (8 out of 12 patents)

6. Jer-Kang Chen (7 out of 13 patents)

7. Robert B Dubridge (6 out of 47 patents)

8. David H Lloyd (5 out of 7 patents)

9. Michael C Pallas (5 out of 28 patents)

10. George Stefan Golda (4 out of 28 patents)

11. John Bridgham (4 out of 13 patents)

12. Sarah N McCurdy (4 out of 4 patents)

13. Kevin P Corcoran (4 out of 11 patents)

14. Karen L Fearon (3 out of 26 patents)

15. Bernard L Hirschbein (3 out of 6 patents)

Core Competencies:

Polynucleotide Sequencing

Oligonucleotide Tags

Gene Expression Profiling

Massively Parallel Sequencing

Solid Phase Synthesis

Electrophoresis Apparatus

Adaptor-Based Sequence Analysis

Isothermal Amplification

Differential Gene Expression

DNA Extension Techniques

Restriction Fragment Mapping

Zygosity Determination

56 patents: Sort by Forward Citations

1. 6831994 - System and apparatus for sequential processing of analytes (2004-12-14),

2. 6806052 - Planar arrays of microparticle-bound polynucleotides (2004-10-19),

3. 6720179 - Method and compositions for ordering restriction fragments (2004-04-13),

4. 6654505 - System and apparatus for sequential processing of analytes (2003-11-25),

5. 6653077 - Method of screening for genetic polymorphism (2003-11-25),

6. 6518023 - Method of mapping restriction sites in polynucleotides (2003-02-11),

7. 6511802 - Solid phase selection of differentially expressed genes (2003-01-28),

8. 6406848 - Planar arrays of microparticle-bound polynucleotides (2002-06-18),

9. 6352828 - Oligonucleotide tags for sorting and identification (2002-03-05),

10. 6306597 - DNA sequencing by parallel oligonucleotide extensions (2001-10-23),

11. 6280935 - Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags (2001-08-28),

12. 6265163 - Solid phase selection of differentially expressed genes (2001-07-24),

13. 6235475 - Oligonucleotide tags for sorting and identification (2001-05-22),

14. 6228589 - Measurement of gene expression profiles in toxicity determination (2001-05-08),

15. 6214191 - Electrophoresis apparatus and method (2001-04-10),

Lynx Therapeutics, Inc. is a biotechnology company that specializes in the development and commercialization of advanced gene expression analysis technologies. With a focus on high-throughput sequencing and target enrichment solutions, Lynx Therapeutics offers innovative tools and services that enable researchers to study variations in gene expression across various biological systems. By providing cutting-edge technologies, Lynx Therapeutics aids scientists in advancing their understanding of complex biological processes and facilitates the development of personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

56 Patents

#9 in Hayward, CA

#1,447 in California

#6,135 in US

#12,351 in the World

Hayward, CA, United States of America

Lynx Therapeutics, Inc.

Forward Citations = 10,147

25 inventors:

Sydney Brenner (28 out of 92 patents)

Sergei M Gryaznov (19 out of 83 patents)

Ronald G Schultz (10 out of 16 patents)

4. Stephen C Macevicz (8 out of 22 patents)

5. Glenn Albrecht (8 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…